Investigation of new cytogenetic biomarkers specific to high-LET radiation using in vivo and in vitro exposed human lymphocytes
-
- TSUJI Satsuki
- Radiation Center for Radiation Protection, National Institute of Radiological Sciences
-
- KANDA Reiko
- Radiation Center for Radiation Protection, National Institute of Radiological Sciences
-
- MINAMIHISAMATSU Masako
- Radiation Center for Radiation Protection, National Institute of Radiological Sciences
-
- OHMACHI Yasushi
- Radiation Center for Radiation Protection, National Institute of Radiological Sciences
-
- HIRAOKA Takeshi
- Fundamental Technology Center, National Institute of Radiological Sciences
-
- SHIMADA Yoshiya
- Radiation Center for Radiation Protection, National Institute of Radiological Sciences
-
- OGIU Toshiaki
- Radiation Center for Radiation Protection, National Institute of Radiological Sciences
-
- OHNO Tatsuya
- Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
-
- HAYATA Isamu
- Radiation Center for Radiation Protection, National Institute of Radiological Sciences
Bibliographic Information
- Other Title
-
- 放射線被ばくの細胞遺伝学的線質指標の探索
Abstract
The aim of this study is to find detectable cytogenetic biomarkers that can offer information about the radiation quality of in vivo exposure retrospectively. Chromosome-type aberrations of peripheral lymphocytes of uterine cancer patients that received internal gamma- and external X-ray therapy or carbon beam therapy and of victims severely exposed to neutrons and gamma-rays in a criticality accident that occurred in Tokai-mura, Japan were analyzed. Data obtained from in vitro irradiated experiments using 60Co gamma-rays and 10 MeV neutrons were compared with the in vivo exposed data. As a result, the ratio of acentric rings to dicentric chromosomes (termed RaD ratio) and that of excess fragments to dicentrics (termed EfD ratio) showed significant differences between the two groups of cancer patients, and these ratios for accidental victims were in between the values of the two groups of cancer patients. The in vitro studies using doses equivalent to 1-3 Gy of gamma-rays have confirmed that the EfD ratios were increased with the high LET (linear energy transfer) and RaD ratios decreased. The present data show that the RaD and EfD ratios can be used as cytogenetic biomarkers of exposure to high-LET radiation at least within a few years of exposure.
Journal
-
- The Japan Radiation Research Society Annual Meeting Abstracts
-
The Japan Radiation Research Society Annual Meeting Abstracts 2006 (0), 250-250, 2006
The Japanese Radiation Research Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205639564672
-
- NII Article ID
- 130006999448
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed